JasleenKaurRandhawaMD

PubMed

• 3 citations
  Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised...
  Garcia-Manero, G., McCloskey, J., Griffiths, E., Yee, K., Zeidan, A., Al-Kali, A., Deeg, H., Patel, P., Sabloff, M., Keating, M., Zhu, N., Gabrail, N., Fazal, S., Maly...> ;The Lancet. Haematology. 2024 Jan 1
• Use of ifosfamide, carboplatin and etoposide in combination with brentuximab vedotin or romidepsin based on CD30 positivity in relapsed/refractory peripheral T-cell ly...
  Cesar Gentille, Humaira Sarfraz, Jitesh Joshi, Jasleen Randhawa, Shilpan Shah, Sai Ravi Pingali> ;Cancer Reports. 2022 Jul 1
• 32 citations
  Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
  Premal Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Suhasini Lulla, George Carrum, Carlos A. Ramos, Rammurti T. Kamble,...> ;Blood. 2021 May 13
• 1 citations
  The development of T-cell malignancies in patients with pre-existing myeloproliferative neoplasms: a report of three cases
  Ethan Burns, Kartik Anand, Betty Chung, Shilpan S. Shah, Jasleen K. Randhawa, Sai Ravi Pingali> ;Ecancermedicalscience. 2020 Feb 17
• 4 citations
  Primary CNS Lymphoma Arising from the 4th Ventricle: A Case Report and Review of the Literature
  Ava Brozovich, Donald C. Ewing, Ethan Burns, Courtney Hatcher, Gonzalo Acosta, Usman Khan, Betty Chung, Leena Samuel, Jasleen K. Randhawa, Sai Ravi Pingali> ;Case Reports in Oncological Medicine. 2019 Apr 10
• 8 citations
  Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high C...
  Parameswaran Hari, Donna E. Reece, Jasleen K Randhawa, Neal Flomenberg, Dianna S. Howard, A. Badros, Aaron P. Rapoport, Joanne Filicko-O'Hara, Gordon L. Phillips, Davi...> ;Bone Marrow Transplantation. 2019 Feb 1
• 12 citations
  A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
  Iman Abou Dalle, Jorge E. Cortes, Pramod Pinnamaneni, Betty Lamothe, Adolfo Enrique Diaz Duque, Jasleen K. Randhawa, Naveen Pemmaraju, Elias Jabbour, Alessandra Ferraj...> ;Acta Haematologica. 2018 Sep 1
• 20 citations
  An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
  May Daher, Juliana E. Hidalgo Lopez, Jasleen K. Randhawa, Kausar J. Jabbar, Yue Wei, Naveen Pemmaraju, Gautam Borthakur, Tapan M. Kadia, Marina Konopleva, Hagop M. Kan...> ;American Journal of Hematology. 2017 Jul 1
• 5 citations
  A review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia
  Jasleen K. Randhawa, Alessandra Ferrajoli> ;Expert Review of Hematology. 2016 Feb 24
• 2 citations
  Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
  Jasleen K Randhawa, Stuart J. Wong, Ehab Atallah, Edit Olasz> ;International Journal of Dermatology. 2014 Jan 1
• 23 citations
  Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
  Jasleen K Randhawa, Alen Ostojić, Radovan Vrhovac, Ehab Atallah, Srdan Verstovsek> ;Journal of Hematology & Oncology. 2012 Aug 1
• Join now to see all

Journal Articles

• Final Outcomes of Escalated Melphalan 280 mg/m2 with Amifostine Cytoprotection Followed Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: High C...  
  Neal Flomenberg, Dianna S Howard, Barry R Meisenberg, Parameswaran Hari, Gordon L Phillips, David H Vesole, Jasleen Randhawa, Aaron P Rapoport, Nature

Abstracts/Posters

• Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis from 2005-2016
  Jasleen K. Randhawa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019